NCT02573493 - Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 13, 2016

Primary Completion Date

December 12, 2019

Study Completion Date

July 1, 2024

Conditions

Squamous Cell Carcinoma of the Head and NeckCarcinoma, Squamous Cell of the Head and NeckCancer of Head and NeckCancer of the Head and NeckHead and Neck CancerNeoplasms, Head and Neck

Interventions

DRUG

nab-Paclitaxel

DRUG

Cisplatin

BIOLOGICAL

Cetuximab

RADIATION

Intensity-Modulated Radiation Therapy

Trial Locations (3)

57104

Sanford Cancer Center, Sioux Falls

63110

Washington University School of Medicine, St Louis

66205

The University of Kansas Cancer Center and Medical Pavilion, Westwood